Allianz Asset Management GmbH - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 104 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q2 2021$212,000
-90.7%
60,468
-73.9%
0.00%
-100.0%
Q1 2021$2,282,000
-11.0%
231,435
-2.1%
0.00%
-33.3%
Q4 2020$2,563,000
-7.9%
236,439
-12.5%
0.00%0.0%
Q3 2020$2,782,000
-44.4%
270,091
+12.7%
0.00%
-50.0%
Q2 2020$5,002,000
+69.4%
239,608
-20.7%
0.01%
+50.0%
Q1 2020$2,952,000
-4.0%
302,206
+13.3%
0.00%
+33.3%
Q4 2019$3,074,000
+702.6%
266,816
+279.4%
0.00%
Q3 2019$383,00070,3320.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2019
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,109,867$42,332,00029.76%
Versant Venture Management, LLC 7,003,892$72,140,00013.20%
Ghost Tree Capital, LLC 1,161,375$11,962,0003.46%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$4,944,0002.54%
Soleus Capital Management, L.P. 364,349$3,753,0001.99%
RTW INVESTMENTS, LP 7,234,764$74,518,0001.79%
RA Capital Management 9,410,860$96,932,0001.77%
FRAZIER MANAGEMENT LLC 1,437,028$14,801,0001.33%
Casdin Capital, LLC 2,750,000$28,325,0001.27%
Avoro Capital Advisors LLC 8,000,000$82,400,0001.17%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders